Alliance Pharma PLC (AIM: APH): Â Alternative Investment Market-listed APH stocks registered a new 52-week high of GBX 87.90/- as on January 22, 2020, after reporting decent full-year performance for FY19.
APH is a UK-based, speciality pharmaceutical company. The Â£456.35m market-cap group is engaged in the acquisition, marketing and distribution of pharmaceutical products. The Group's products offering includes prescription-only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements.Â As on December 17, 2015, its shares were admitted to the AIM-segment of the London Stock Exchange for trading and it is a constituent company of the FTSE AIM UK 50 index, FTSE AIM 100 index and FTSE AIM AllShare index.
Recently (as on January 22, 2020), the pharmaceutical company reported its full-year trading report for the financial year ended as on December 31, 2019. Â During the period under consideration, the pharmaceutical company's see-through revenue leapt by 16% to Â£144.3m against Â£124.0m reported in a year-ago period. However, organic revenue growth (excluding acquisitions) was 9% for FY19 and 8% on a constant currency basis.
The revenue growth in FY19 was underpinned by solid performance the Group's international star brands like Kelo-coteâ¢ (revenue surged to Â£31.0m against Â£22.5m reported in FY18, up 38% on YoY basis), and Nizoralâ¢, which was under Johnson & Johnson management in 2019, generated a see through revenue* of Â£20.2m against Â£10.9m in the second half of 2018. Also, MacuShieldâ¢ witnessed solid growth in 2019, with revenues surging by 18% on a YoY basis to Â£8.2m and Vamousseâ¢ - recorded another year of strong performance with revenues surging by 14% to Â£6.5m and increased 10% on a constant currency basis, which reflects that the product registered continuous outperformance against the general market in the United States, its biggest sales market.
However, the Group's local brands also reported modest performance during the FY19, with revenue for the year standing at Â£78.4m against Â£77.8m in FY18.
It also reported strong free cash flow of Â£29.1m against a free cash flow of Â£16.1m reported in the FY18. The Group has significantly reduced risks from its balance sheet at the end of FY19, as Net Debt was significantly brought down to Â£59.2m at 31 December 2019 against Â£74.1m recorded at the end of H1FY19 and Â£85.8m at the end of FY18.
There was a significant reduction in the companyâs net debt as a result of the healthy cash generation in 2019.
The Group is due to report its full-year results as on March 24, 2020.
Daily price chart (as on January 23, 2020, before the market close). Source: Thomson Reuters
On a YoY basis, APH stock delivered a price return of approximately 33%, up by approximately 22% in the past three months, bagged approximately 6% over one month and went up by about 5% in the past five trading sessions. The prevailing trend is positive in the stock.
In the year-ago period, APH stocks registered a 52-week high of GBX 87.90 (as on January 22, 2020) and a 52-week low of GBX 61.0 (as on February 01, 2019), while at the current market price of GBX 86.3 (as of January 23, 2020, at 10:20 AM GMT), the stock traded approximately 1.82% lower against its 52-week peak level and around 41.4% above its 52-week low price level, respectively.
In addition to a decent return that APH shares have handed to its shareholders in the year-over period, it is also offering a decent dividend yield of 1.78% at the current price level.
The current price level is more tilted towards its 52-week high price level, which is typically considered to be positive trend in the stock, also, at the current traded level, its stock traded well-above its short-term as well as long-term support levels of 5-day, 10-day, 20-day, 50-day, 100-day and 200-day SMAs, which is typically considered to be favourable technical trend in the stock. Also, the difference between the 120-day exponential moving average (EMA) and the 26-day exponential moving average is positive, which is broadly considered as a positive trend in any stock.
Sumo Group PLC (LON: SUMO): Â Shares of United Kingdom-based leisure company- Sumo Group PLC registered a new 52-week high of GBX 205 (as on January 22, 2020), post it reported it full-year trading update for FY19, which stated that full year performance would be broadly in line with the expectations.
The Â£298.19m market-cap Sumo Group PLC is an AIM-listed gaming and leisure company. The Group which is engaged in providing creative and development services to the video games and entertainment industries, the Group's primary business, is one of the UK's largest independent developers of AAA-rated video games, having studios in Sheffield, Newcastle, Nottingham, Leeds, Leamington Spa, Warrington and Pune, India.
Recently (as on January 22, 2020), the Group reported its full-year trading update for the year ended as on December 31, 2019. In which the Group communicated that the full-year trading is expected to be at least in line with the expectations, which is due to report on April 01, 2020.
Group's chief executive commented that 2019 was yet another successful year for the company and it could generate decent growth across the business segments. During the past year, the Group made an acquisition of Red Kite Games and opened new studios in Warrington and Leamington Spa. It also shifted the Red Kite Games studio to the talent hot spot of central Leeds from Huddersfield.
He also added that the company is witnessing many more opportunities to deliver growth in its core markets which are served by Sumo Digital and Atomhawk.
At the end of FY19, the leisure company reported a positive cash position of Â£12.9m and employee strength increased by 174 to 766 during the same period.
Â Daily price chart (as on January 23, 2020, before the market close). Source: Thomson Reuters.
Over the year-long period, SUMO stocks have delivered a price return of approximately 55%, up by around 26% in the past three months, bagged approximately 20% in a period of one month and added about 6% in the last five trading sessions.
In the year-over period, SUMO stocks have registered a 52-week high of GBX 205.0 and a 52-week low of GBX 118.0, and at the current trading level of GBX 198.0 (as on January 23, 2020, at 10: 40 AM GMT) traded approximately 3% lower against its 52-week traded level and around 68% above its 52-week low price level, which reflects that at the current price level, the stock is oscillating near its 52-week high price level, which is typically considered to be a favourable trend in the stock.
Also, at the current price level, the stock traded above its 5-day, 10-day, 20-day, 50-day, 100-day and 200-day SMAs, which acts as crucial support levels in the stock. Also, a CMP significantly above its 200-day SMAs is typically considered as a favourable trend in the stock.
However, at the current traded level, SUMO's PE(x) ration stood significantly above against industry average at 151.25x, whereas industry average PE(x) multiple stood at 28.06x, which reflects that the SUMO stock is trading at a substantially higher premium against the industry peers.